Tone mix
Week by week 50 weeks
Share of UroGen Pharma Ltd. Ordinary Shares's 214 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jul 7, 2025 · tone +100UroGen Pharma Receives FDA Approval for ZUSDURI for Recurrent Bladder Cancer+120
- Week of Jul 6, 2026 · tone +100UroGen Pharma Announces FDA Clearance Of IND For UGN-501+112
- Week of Nov 10, 2025 · tone +100Urogen Pharma (NASDAQ:URGN) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS+100
- Week of Apr 28, 2025 · tone +100UroGen Pharma Touts Four-Year Response With Urothelial Cancer Drug Study, Highlights Potential For Bladder Cancer Candidates+90
- Week of Jun 29, 2026 · tone -95Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Let Go of 10,000 Shares?-84
- Week of Oct 19, 2026 · tone +100Urogen Pharma's (URGN) Buy Rating Reaffirmed at HC Wainwright+75
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about UroGen Pharma Ltd. Ordinary Shares in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 1 | 0 |
| Last 30 sessions | 10 | +45 |
| Last 90 sessions | 31 | +21 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletUroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026 | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
2 headlines, average tone +100: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletUrogen Pharma's (URGN) Buy Rating Reaffirmed at HC WainwrightPositive
- www.rttnews.com · 1 outletUroGen Pharma Announces FDA Acceptance Of UGN-103 NDA For ReviewPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Urogen Pharma's (URGN) Buy Rating Reaffirmed at HC Wainwright | www.themarketsdaily.com | 1 | Positive |
| UroGen Pharma Announces FDA Acceptance Of UGN-103 NDA For Review | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletUrogen Pharma (NASDAQ:URGN) Stock Rated "Moderate Buy" by Wall Street BrokeragesPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Urogen Pharma (NASDAQ:URGN) Stock Rated "Moderate Buy" by Wall Street Brokerages | www.themarketsdaily.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
2 headlines, average tone +30: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletUrogen Pharma (NASDAQ:URGN) Stock Has Average Price Target of $52.38 According to BrokeragesPositive
- www.themarketsdaily.com · 1 outletAnalyzing Urogen Pharma (NASDAQ:URGN) and Incannex Healthcare (NASDAQ:IXHL)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Urogen Pharma (NASDAQ:URGN) Stock Has Average Price Target of $52.38 According to Brokerages | www.dailypolitical.com | 1 | Positive |
| Analyzing Urogen Pharma (NASDAQ:URGN) and Incannex Healthcare (NASDAQ:IXHL) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletReviewing Cronos Group (NASDAQ:CRON) and Urogen Pharma (NASDAQ:URGN)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Reviewing Cronos Group (NASDAQ:CRON) and Urogen Pharma (NASDAQ:URGN) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about UroGen Pharma Ltd. Ordinary Shares, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.